What is the price-to-earnings ratio of Instem?
The price-earnings ratio of Instem is currently 2.59.
Instem P/S 2024
Instem P/S
2.59
Ticker
INS.L
ISIN
GB00B3TQCK30
WKN
A1C7NS
As of Sep 6, 2024, Instem's P/S ratio stood at 2.59, a 18.26% change from the 2.19 P/S ratio recorded in the previous year.
The Instem P/S history
Instem Aktienanalyse
What does Instem do?
Instem PLC is a company specialized in providing software solutions for the health and life sciences. It is headquartered in Abingdon, Oxfordshire and operates internationally. The company was founded in 2000 and has been listed on the London Stock Exchange since 2004. Instem's business model is based on helping life science companies optimize and automate their workflows. They offer a wide range of software products tailored to the specific needs of their customers. This includes systems for documenting animal experiments, clinical data collection, and solutions for regulatory drug submissions. One of Instem's key divisions is the Preclinical Solutions Division, which helps life science companies effectively plan and conduct their preclinical studies. The products in this division support the creation of study protocols, planning experimental procedures, and documenting study results. Additionally, customers of the Preclinical Solutions Division can access assistance with data collection and analysis, as well as comprehensive consulting services. Another important division of Instem is the Clinical Solutions Division, which supports clinical research facilities in conducting clinical trials. Their solutions include clinical data collection, study monitoring, and data submission to regulatory authorities. The Clinical Solutions Division also provides support for quality control and the production of statistical reports. Instem is also active in other areas, such as in vitro diagnostics and chemical approval. In these fields, the company offers a range of software solutions that aid in data collection, analysis, and reporting. A key factor that sets Instem apart from its competitors is its close collaboration with the life science community. The company works closely with customers, regulatory agencies, and interest groups to ensure that its products meet industry requirements and standards. In addition, the company has established close relationships with leading clinical and research institutions worldwide. In summary, Instem PLC is a significant provider of software solutions for the health and life sciences. The company has experienced impressive growth in recent years and strengthened its position in key market segments. Instem is well positioned to continue benefiting from the increasing demand for software solutions in the health and life sciences industry. Instem ist eines der beliebtesten Unternehmen auf Eulerpool.com.P/S Details
Decoding Instem's P/S Ratio
Instem's Price to Sales (P/S) Ratio is a crucial financial metric that measures the company's market valuation relative to its total sales revenue. It's calculated by dividing the company's market capitalization by its total sales over a specific period. A lower P/S ratio can indicate that the company is undervalued, while a higher ratio may suggest overvaluation.
Year-to-Year Comparison
Comparing Instem's P/S ratio yearly provides insights into how the market perceives the company’s value relative to its sales. An increasing ratio over time can indicate growing investor confidence, while a decreasing trend might reflect concerns about the company’s revenue generation capabilities or market conditions.
Impact on Investments
The P/S ratio is instrumental for investors evaluating Instem's stock. It offers insights into the company’s efficiency in generating sales and its market valuation. Investors use this ratio to compare similar companies within the same industry, aiding in selecting stocks that offer the best value for investment.
Interpreting P/S Ratio Fluctuations
Variations in Instem’s P/S ratio can result from changes in the stock price, sales revenue, or both. Understanding these fluctuations is crucial for investors to evaluate the company’s current valuation and future growth potential, aligning their investment strategies accordingly.
Frequently Asked Questions about Instem stock
How has the price-earnings ratio of Instem changed compared to last year?
The price-to-earnings ratio of Instem has increased by 18.26% increased compared to last year.
What consequences does a high price-earnings ratio have for investors?
A high price-to-earnings ratio indicates that the company's stock is relatively expensive and investors may potentially achieve a lower return.
What does a low price-earnings ratio mean?
A low price-earnings ratio means that the company's stock is relatively cheap and investors may potentially achieve a higher return.
Is the price-earnings ratio of Instem high compared to other companies?
Yes, the price-to-earnings ratio of Instem is high compared to other companies.
How does an increase in the price-earnings ratio of Instem affect the company?
An increase in the price-earnings ratio of Instem would lead to a higher market capitalization of the company, which in turn would lead to a higher valuation of the company.
How does a reduction in the price-to-earnings ratio of Instem affect the company?
A decrease in the price-earnings ratio of Instem would result in a lower market capitalization of the company, which in turn would lead to a lower valuation of the company.
What are some factors that influence the price-earnings ratio of Instem?
Some factors that influence the price-earnings ratio of Instem are the company's growth, financial position, industry development, and the overall economic situation.
How much dividend does Instem pay?
Over the past 12 months, Instem paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Instem is expected to pay a dividend of 0 GBP.
What is the dividend yield of Instem?
The current dividend yield of Instem is .
When does Instem pay dividends?
Instem pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of Instem?
Instem paid dividends every year for the past 0 years.
What is the dividend of Instem?
For the upcoming 12 months, dividends amounting to 0 GBP are expected. This corresponds to a dividend yield of 0 %.
In which sector is Instem located?
Instem is assigned to the 'Health' sector.
Wann musste ich die Aktien von Instem kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Instem from 9/6/2024 amounting to 0 GBP, you needed to have the stock in your portfolio before the ex-date on 9/6/2024.
When did Instem pay the last dividend?
The last dividend was paid out on 9/6/2024.
What was the dividend of Instem in the year 2023?
In the year 2023, Instem distributed 0 GBP as dividends.
In which currency does Instem pay out the dividend?
The dividends of Instem are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von Instem
Our stock analysis for Instem Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Instem Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
